Liver abnormalities in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Liver abnormalities in pulmonary arterial hypertension

Published:2021-10 Issue:4 Volume:11 Page:1-12
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Nickel Nils P.¹^ORCID,Galura Gian M.²,Zuckerman Marc J.²,Hakim M. Nawar³,Alkhateeb Haider⁴,Mukherjee Debabrata⁴^ORCID,Austin Eric D.⁵^ORCID,Heresi Gustavo A.⁶^ORCID

Affiliation:

1. Division of Pulmonary and Critical Care MedicineTexas Tech University Health Sciences CenterEl PasoTXUSA

2. Division of GastroenterologyTexas Tech University Health Sciences CenterEl PasoTXUSA

3. Department of PathologyTexas Tech University Health Sciences CenterEl PasoTXUSA

4. Division of Cardiovascular MedicineTexas Tech University Health Sciences CenterEl PasoTXUSA

5. Division of Pediatric Pulmonary MedicineVanderbilt UniversityNashvilleTNUSA

6. Division of Pulmonary and Critical Care MedicineCleveland ClinicOHUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/20458940211054304

Reference118 articles.

1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau G;Eur Respir J,2019

2. Beyond the lungs: systemic manifestations of pulmonary arterial hypertension.;Nickel NP;Am J Respir Crit Care Med,2020

3. Systemic consequences of pulmonary hypertension and right‐sided heart failure.;Rosenkranz S;Circulation,2020

4. Model for end‐stage liver disease and pneumonia: an improved scoring model for critically ill cirrhotic patients with pneumonia.;Gao F;Turk J Gastroenterol,2019

5. Pulmonary manifestations among patients with primary biliary cirrhosis.;Koksal D;J Clin Transl Hepatol,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study;International Journal of General Medicine;2024-09

2. Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH;Blood Reviews;2024-09

3. Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension;Diagnostics;2024-08-21

4. Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data;International Journal of Clinical Pharmacy;2024-06-20

5. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in Patients with Lupus Nephritis;Medicina;2024-06-17